Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/24/2020 36 38
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Dec/22/2020 24 5
Azithromycin Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/04/2020 17 6
Niclosamide Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/04/2020 7 0
Remdesivir Approved by FDA Experimental Antiviral Dec/02/2020 48 4
Nelfinavir mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/26/2020 9 1
Heparin Potential treatment - clinical evidence Used to treat other disease Antiviral Nov/10/2020 11 1
Aprotinin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Oct/30/2020 3 0
Cepharanthine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jul/11/2020 4 0
MK-2206 Potential treatment - pre-clinical evidence Experimental Antiviral Jun/16/2020 2 0